-
1
-
-
79953276254
-
SnapShot: The epithelial-mesenchymal transition
-
Sleeman JP and Thiery JP. SnapShot: The epithelial-mesenchymal transition. Cell. 2011; 145: 162 e161.
-
(2011)
Cell
, vol.145
, pp. 162
-
-
Sleeman, J.P.1
Thiery, J.P.2
-
2
-
-
70450198396
-
Epithelial-mesenchymal transitions in development and disease
-
Thiery JP, Acloque H, Huang RY and Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139: 871-890.
-
(2009)
Cell
, vol.139
, pp. 871-890
-
-
Thiery, J.P.1
Acloque, H.2
Huang, R.Y.3
Nieto, M.A.4
-
3
-
-
84872200824
-
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
-
Huang RY, Guilford P and Thiery JP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci. 2012; 125: 4417-4422.
-
(2012)
J Cell Sci
, vol.125
, pp. 4417-4422
-
-
Huang, R.Y.1
Guilford, P.2
Thiery, J.P.3
-
4
-
-
43049165453
-
The epithelial-mesenchymal transition generates cells with properties of stem cells
-
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008; 133: 704-715.
-
(2008)
Cell
, vol.133
, pp. 704-715
-
-
Mani, S.A.1
Guo, W.2
Liao, M.J.3
Eaton, E.N.4
Ayyanan, A.5
Zhou, A.Y.6
Brooks, M.7
Reinhard, F.8
Zhang, C.C.9
Shipitsin, M.10
Campbell, L.L.11
Polyak, K.12
Brisken, C.13
Yang, J.14
Weinberg, R.A.15
-
5
-
-
79956351015
-
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
-
Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, Brooks M, Reinhardt F, Su Y, Polyak K, Arendt LM, Kuperwasser C, Bierie B and Weinberg RA. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A. 2011; 108: 7950-7955.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, pp. 7950-7955
-
-
Chaffer, C.L.1
Brueckmann, I.2
Scheel, C.3
Kaestli, A.J.4
Wiggins, P.A.5
Rodrigues, L.O.6
Brooks, M.7
Reinhardt, F.8
Su, Y.9
Polyak, K.10
Arendt, L.M.11
Kuperwasser, C.12
Bierie, B.13
Weinberg, R.A.14
-
6
-
-
84889570568
-
An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
-
Huang RY, Wong MK, Tan TZ, Kuay KT, Ng AH, Chung VY, Chu YS, Matsumura N, Lai HC, Lee YF, Sim WJ, Chai C, Pietschmann E, Mori S, Low JJ, Choolani M, et al. An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530). Cell Death Dis. 2013; 4: e915.
-
(2013)
Cell Death Dis
, vol.4
-
-
Huang, R.Y.1
Wong, M.K.2
Tan, T.Z.3
Kuay, K.T.4
Ng, A.H.5
Chung, V.Y.6
Chu, Y.S.7
Matsumura, N.8
Lai, H.C.9
Lee, Y.F.10
Sim, W.J.11
Chai, C.12
Pietschmann, E.13
Mori, S.14
Low, J.J.15
Choolani, M.16
-
7
-
-
33244463813
-
Complex networks orchestrate epithelial-mesenchymal transitions
-
Thiery JP and Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006; 7: 131-142.
-
(2006)
Nat Rev Mol Cell Biol
, vol.7
, pp. 131-142
-
-
Thiery, J.P.1
Sleeman, J.P.2
-
9
-
-
84875279977
-
Cadherins and epithelial-to-mesenchymal transition
-
Gheldof A and Berx G. Cadherins and epithelial-to-mesenchymal transition. Prog Mol Biol Transl Sci. 2013; 116: 317-336.
-
(2013)
Prog Mol Biol Transl Sci
, vol.116
, pp. 317-336
-
-
Gheldof, A.1
Berx, G.2
-
10
-
-
84908086125
-
Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients
-
Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY and Thiery JP. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014; 6: 1279-1293.
-
(2014)
EMBO Mol Med
, vol.6
, pp. 1279-1293
-
-
Tan, T.Z.1
Miow, Q.H.2
Miki, Y.3
Noda, T.4
Mori, S.5
Huang, R.Y.6
Thiery, J.P.7
-
11
-
-
79959944022
-
Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept
-
Chua KN, Poon KL, Lim J, Sim WJ, Huang RY and Thiery JP. Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept. Adv Drug Deliv Rev. 2011; 63: 558-567.
-
(2011)
Adv Drug Deliv Rev
, vol.63
, pp. 558-567
-
-
Chua, K.N.1
Poon, K.L.2
Lim, J.3
Sim, W.J.4
Huang, R.Y.5
Thiery, J.P.6
-
12
-
-
68749108255
-
Breast cancer stem cells: eradication by differentiation therapy?
-
Beug H. Breast cancer stem cells: eradication by differentiation therapy? Cell. 2009; 138: 623-625.
-
(2009)
Cell
, vol.138
, pp. 623-625
-
-
Beug, H.1
-
13
-
-
68749099671
-
Identification of selective inhibitors of cancer stem cells by high-throughput screening
-
Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA and Lander ES. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell. 2009; 138: 645-659.
-
(2009)
Cell
, vol.138
, pp. 645-659
-
-
Gupta, P.B.1
Onder, T.T.2
Jiang, G.3
Tao, K.4
Kuperwasser, C.5
Weinberg, R.A.6
Lander, E.S.7
-
14
-
-
84866371806
-
Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells
-
Carmody LC, Germain AR, Ver Plank L, Nag PP, Munoz B, Perez JR and Palmer MA. Phenotypic high-throughput screening elucidates target pathway in breast cancer stem cell-like cells. J Biomol Screen. 2012; 17: 1204-1210.
-
(2012)
J Biomol Screen
, vol.17
, pp. 1204-1210
-
-
Carmody, L.C.1
Germain, A.R.2
Ver Plank, L.3
Nag, P.P.4
Munoz, B.5
Perez, J.R.6
Palmer, M.A.7
-
15
-
-
84863247475
-
A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma
-
Chua KN, Sim WJ, Racine V, Lee SY, Goh BC and Thiery JP. A cell-based small molecule screening method for identifying inhibitors of epithelial-mesenchymal transition in carcinoma. PLoS One. 2012; 7: e33183.
-
(2012)
PLoS One
, vol.7
-
-
Chua, K.N.1
Sim, W.J.2
Racine, V.3
Lee, S.Y.4
Goh, B.C.5
Thiery, J.P.6
-
16
-
-
84880019576
-
Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer
-
Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, et al. Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer. EMBO Mol Med. 2013; 5: 983-998.
-
(2013)
EMBO Mol Med
, vol.5
, pp. 983-998
-
-
Tan, T.Z.1
Miow, Q.H.2
Huang, R.Y.3
Wong, M.K.4
Ye, J.5
Lau, J.A.6
Wu, M.C.7
Bin Abdul Hadi, L.H.8
Soong, R.9
Choolani, M.10
Davidson, B.11
Nesland, J.M.12
Wang, L.Z.13
Matsumura, N.14
Mandai, M.15
Konishi, I.16
-
17
-
-
37849050229
-
The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response
-
Schenkel AR, Dufour EM, Chew TW, Sorg E and Muller WA. The murine CD99-related molecule CD99-like 2 (CD99L2) is an adhesion molecule involved in the inflammatory response. Cell Commun Adhes. 2007; 14: 227-237.
-
(2007)
Cell Commun Adhes
, vol.14
, pp. 227-237
-
-
Schenkel, A.R.1
Dufour, E.M.2
Chew, T.W.3
Sorg, E.4
Muller, W.A.5
-
18
-
-
84860273145
-
Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor
-
Nagae M, Re S, Mihara E, Nogi T, Sugita Y and Takagi J. Crystal structure of alpha5beta1 integrin ectodomain: atomic details of the fibronectin receptor. J Cell Biol. 2012; 197: 131-140.
-
(2012)
J Cell Biol
, vol.197
, pp. 131-140
-
-
Nagae, M.1
Re, S.2
Mihara, E.3
Nogi, T.4
Sugita, Y.5
Takagi, J.6
-
19
-
-
84875258658
-
Integrin alpha5beta1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors
-
Schaffner F, Ray AM and Dontenwill M. Integrin alpha5beta1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors. Cancers (Basel). 2013; 5: 27-47.
-
(2013)
Cancers (Basel)
, vol.5
, pp. 27-47
-
-
Schaffner, F.1
Ray, A.M.2
Dontenwill, M.3
-
20
-
-
77149135790
-
A Syd-1 homologue regulates pre-and postsynaptic maturation in Drosophila
-
Owald D, Fouquet W, Schmidt M, Wichmann C, Mertel S, Depner H, Christiansen F, Zube C, Quentin C, Korner J, Urlaub H, Mechtler K and Sigrist SJ. A Syd-1 homologue regulates pre-and postsynaptic maturation in Drosophila. J Cell Biol. 2010; 188: 565-579.
-
(2010)
J Cell Biol
, vol.188
, pp. 565-579
-
-
Owald, D.1
Fouquet, W.2
Schmidt, M.3
Wichmann, C.4
Mertel, S.5
Depner, H.6
Christiansen, F.7
Zube, C.8
Quentin, C.9
Korner, J.10
Urlaub, H.11
Mechtler, K.12
Sigrist, S.J.13
-
21
-
-
84866065861
-
Cooperation of Syd-1 with Neurexin synchronizes pre-with postsynaptic assembly
-
Owald D, Khorramshahi O, Gupta VK, Banovic D, Depner H, Fouquet W, Wichmann C, Mertel S, Eimer S, Reynolds E, Holt M, Aberle H and Sigrist SJ. Cooperation of Syd-1 with Neurexin synchronizes pre-with postsynaptic assembly. Nat Neurosci. 2012; 15: 1219-1226.
-
(2012)
Nat Neurosci
, vol.15
, pp. 1219-1226
-
-
Owald, D.1
Khorramshahi, O.2
Gupta, V.K.3
Banovic, D.4
Depner, H.5
Fouquet, W.6
Wichmann, C.7
Mertel, S.8
Eimer, S.9
Reynolds, E.10
Holt, M.11
Aberle, H.12
Sigrist, S.J.13
-
22
-
-
77955713402
-
Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis
-
Buchner A, Castro M, Hennig A, Popp T, Assmann G, Stief CG and Zimmermann W. Downregulation of HNF-1B in renal cell carcinoma is associated with tumor progression and poor prognosis. Urology. 2010; 76: 507.e6-507.e11.
-
(2010)
Urology
, vol.76
, pp. 507.e6-507.e11
-
-
Buchner, A.1
Castro, M.2
Hennig, A.3
Popp, T.4
Assmann, G.5
Stief, C.G.6
Zimmermann, W.7
-
23
-
-
84879292510
-
BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer
-
Kutluk Cenik B, Ostapoff KT, Gerber DE and Brekken RA. BIBF 1120 (nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer. Mol Cancer Ther. 2013; 12: 992-1001.
-
(2013)
Mol Cancer Ther
, vol.12
, pp. 992-1001
-
-
Kutluk Cenik, B.1
Ostapoff, K.T.2
Gerber, D.E.3
Brekken, R.A.4
-
24
-
-
0027327321
-
The 5' flanking sequences of the mouse P-cadherin gen. Homologies to 5' sequences of the E-cadherin gene and identification of a first 215 base-pair intron
-
Faraldo ML and Cano A. The 5' flanking sequences of the mouse P-cadherin gene. Homologies to 5' sequences of the E-cadherin gene and identification of a first 215 base-pair intron. J Mol Biol. 1993; 231: 935-941.
-
(1993)
J Mol Biol
, vol.231
, pp. 935-941
-
-
Faraldo, M.L.1
Cano, A.2
-
25
-
-
56749095797
-
Transcriptional regulation of cell polarity in EMT and cancer
-
Moreno-Bueno G, Portillo F and Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene. 2008; 27: 6958-6969.
-
(2008)
Oncogene
, vol.27
, pp. 6958-6969
-
-
Moreno-Bueno, G.1
Portillo, F.2
Cano, A.3
-
26
-
-
84875054847
-
P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model
-
Ribeiro AS, Sousa B, Carreto L, Mendes N, Nobre AR, Ricardo S, Albergaria A, Cameselle-Teijeiro JF, Gerhard R, Soderberg O, Seruca R, Santos MA, Schmitt F and Paredes J. P-cadherin functional role is dependent on E-cadherin cellular context: a proof of concept using the breast cancer model. J Pathol. 2013; 229: 705-718.
-
(2013)
J Pathol
, vol.229
, pp. 705-718
-
-
Ribeiro, A.S.1
Sousa, B.2
Carreto, L.3
Mendes, N.4
Nobre, A.R.5
Ricardo, S.6
Albergaria, A.7
Cameselle-Teijeiro, J.F.8
Gerhard, R.9
Soderberg, O.10
Seruca, R.11
Santos, M.A.12
Schmitt, F.13
Paredes, J.14
-
27
-
-
79959850623
-
P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin
-
Cheung LW, Mak AS, Cheung AN, Ngan HY, Leung PC and Wong AS. P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin. Oncogene. 2011; 30: 2964-2974.
-
(2011)
Oncogene
, vol.30
, pp. 2964-2974
-
-
Cheung, L.W.1
Mak, A.S.2
Cheung, A.N.3
Ngan, H.Y.4
Leung, P.C.5
Wong, A.S.6
-
28
-
-
84904662850
-
P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions
-
Usui A, Ko SY, Barengo N and Naora H. P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions. Mol Cancer Res. 2014; 12: 504-513.
-
(2014)
Mol Cancer Res
, vol.12
, pp. 504-513
-
-
Usui, A.1
Ko, S.Y.2
Barengo, N.3
Naora, H.4
-
29
-
-
84923383604
-
miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13
-
Zhang P, Wang L, Rodriguez-Aguayo C, Yuan Y, Debeb BG, Chen D, Sun Y, You MJ, Liu Y, Dean DC, Woodward WA, Liang H, Yang X, Lopez-Berestein G, Sood AK, Hu Y, et al. miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun. 2014; 5: 5671.
-
(2014)
Nat Commun
, vol.5
, pp. 5671
-
-
Zhang, P.1
Wang, L.2
Rodriguez-Aguayo, C.3
Yuan, Y.4
Debeb, B.G.5
Chen, D.6
Sun, Y.7
You, M.J.8
Liu, Y.9
Dean, D.C.10
Woodward, W.A.11
Liang, H.12
Yang, X.13
Lopez-Berestein, G.14
Sood, A.K.15
Hu, Y.16
-
30
-
-
76549129820
-
Drug combination studies and their synergy quantification using the Chou-Talalay method
-
Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70: 440-6.
-
(2010)
Cancer Res
, vol.70
, pp. 440-446
-
-
Chou, T.C.1
|